- Pfizer seeking approval to jab kids aged six months to five years by this winter
- Timeline will depend on findings of in-house trials of vaccines on young children
- Pfizer’s jab already being used for over-12s in majority of countries in the West
Pfizer’s Covid vaccine could be rolled out to babies as young as six months in the US this winter, under plans being drawn up by the pharmaceutical giant.
In a move likely to cause international controversy, the company intends to apply for authorisation to immunise American infants within the next two months.
The timeline will depend on the findings of in-house trials looking into whether the vaccines are safe and effective in youngsters aged six months to five years.
Frank D’Amelio, chief financial officer at Pfizer, told an industry conference yesterday that the firm plans to ‘go file’ by November, the Financial Times reports.